|
ATCC
dld1 cells human atcc ccl 221 hek293t cells Dld1 Cells Human Atcc Ccl 221 Hek293t Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pm42998979-210-14-17 Average 99 stars, based on 1 article reviews
dld1 cells human atcc ccl 221 hek293t cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
dld1 Dld1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pm42972081-281-0-15 Average 99 stars, based on 1 article reviews
dld1 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
hct116 Hct116, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pm42883769-261-7-13 Average 99 stars, based on 1 article reviews
hct116 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
dld 1 ccl 221 Dld 1 Ccl 221, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pm42884073-215-8-14 Average 99 stars, based on 1 article reviews
dld 1 ccl 221 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
dld 1 ![]() Dld 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pmc13670403-161-5-8 Average 99 stars, based on 1 article reviews
dld 1 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
dld 1 colorectal adenocarcinoma cells ![]() Dld 1 Colorectal Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/pmc13745573-350-36-40 Average 99 stars, based on 1 article reviews
dld 1 colorectal adenocarcinoma cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human crc cell lines dld 1 ccl 221 ![]() Human Crc Cell Lines Dld 1 Ccl 221, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dld+1/DLD-1/10__3390_slash_molecules31203606-51-18-31 Average 99 stars, based on 1 article reviews
human crc cell lines dld 1 ccl 221 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
Journal: Chemistry & Biodiversity
Article Title: Biological Activities and Phytochemical Composition of Arum rupicola var. rupicola : An In Vitro and In Silico Study
doi: 10.1002/cbdv.71785
Figure Lengend Snippet: Cell viability graphs of studied cell lines (A: DLD‐1; B: HL‐60 and C: HUVEC cell lines).
Article Snippet: Cytotoxicity studies were conducted using
Techniques:
Journal: Chemistry & Biodiversity
Article Title: Biological Activities and Phytochemical Composition of Arum rupicola var. rupicola : An In Vitro and In Silico Study
doi: 10.1002/cbdv.71785
Figure Lengend Snippet: Selectivity indices of the extracts against the cell lines.
Article Snippet: Cytotoxicity studies were conducted using
Techniques:
Journal: Nature Communications
Article Title: Targeting MDA5 induces immunogenic cell death and promotes anti-tumor immunity
doi: 10.1038/s41467-026-78587-6
Figure Lengend Snippet: a Gene set enrichment analysis of RNA-seq data showing the top 5 upregulated and downregulated pathways in MDA5 knockout MC38 cells compared with control, n = 1 control and n = 2 MDA5 KO . b Gene set enrichment analysis of the unfolded protein response signature in MDA5 knockout cells compared with control MC38 cells, n = 1 control and n = 2 MDA5 KO . Levels of extracellular ATP ( c ) or secreted HMGB1 ( d ) in the conditioned medium (CM) of 10 6 control or MDA5 knockout MC38, Hepa1-6, HCT-15 and DLD-1 cells after treatment with indicated treatments. Data are presented as mean ± SD and n = 3 independent experiments. e Flow cytometry analysis of surface-exposed calreticulin level of MC38, Hepa1-6, HCT-15 and DLD-1 cells after treated with indicated treatments. n = 3 independent experiments. Tumor growth curves ( f ) and tumor weights ( g ) from C57BL/6 mice implanted with control, MDA5 knockout MC38 cells. These mice were treated with or without HMGB1-neutralizing antibody and the P2X7 receptor antagonist A438079. Data are presented as mean ± SEM ( f ) and mean ± SD ( g ), n = 10 tumors/group. h–i A scatter plot showing the correlation between the MDA5-null signature and DAMPs signature, ICD signature or DC activation signature in the E-MTAB-12862 dataset and the TCGA-COADREAD dataset. n = 1063 cases. j Boxplots illustrating the signature score of the DAMPs, ICD and DC activation in the MDA5 wild-type ( n = 1021) and MDA5 loss-of-function (LOF, n = 23) groups, analyzed using the colorectal cancer dataset (E-MTAB-12862). The center line indicates the median, box bounds indicate the 25th and 75th percentiles, and whiskers represent the minimum and maximum values. Statistics were applied using one-sided empirical permutation test with Benjamini–Hochberg adjustment ( a , b ), two-way ANOVA with Tukey’s multiple comparisons test ( c , d , f , g ); two-sided Pearson correlation test ( h , i ); or two-sided Wilcoxon rank-sum test ( j ). Source data are provided as a Source Data file.
Article Snippet: CT26 colon adenocarcinoma cells (ATCC, Cat# CRL-2638, RRID: CVCL_7256), B16-F10 melanoma cells (ATCC, Cat# CRL-6475, RRID: CVCL_0159), Hepa1-6 Hepatocellular carcinoma cells (ATCC, Cat# CRL-1830, RRID: CVCL_0327), HCT-15 colorectal cancer cells (ATCC, Cat# CCL-225, RRID: CVCL_0292) and
Techniques: Gene Set Enrichment Analysis, RNA Sequencing, Knock-Out, Control, Flow Cytometry, Analysis, Activation Assay
Journal: Nature Communications
Article Title: Targeting MDA5 induces immunogenic cell death and promotes anti-tumor immunity
doi: 10.1038/s41467-026-78587-6
Figure Lengend Snippet: a Schematic overview of the in vivo competition assay. b–c Tumor growth curves and cell proportion of Control-GFP+ and MDA5 KO -mCherry+ MC38 cells at different time points after tumor inoculation into immunocompetent mice ( b ) or immunodeficient mice ( c ). n = 6 tumors per point. Illustration of tumor-T cell co-culture experiment performed in Transwell ( d ) and the representative FACS results showing the ratio of MDA5 knockout and control cells in the upper and lower chambers upon the addition of OT-I T cells ( e ), n = 3 independent experiments. f Log2 transformed relative cell viability for MDA5 knockout cells after treated with IFN-γ, TNF-α, or their combination ( n = 3 independent experiments). g Log2 transformed relative cell viability for MDA5 single knockout, or MDA5-TNFR1-IFNGR1 triple knockout MC38 cells after treated with IFN-γ and TNF-α ( n = 6 independent experiments). h WB analysis of MDA5, p-ASK1, ASK1, p-JNK, JNK, p-p38, p38 in MC38 and DLD-1 tumor cells after the indicated treatment. Representative images from three independent experiments. Log2 transformed relative cell viability of MDA5 knockout MC38-OVA cells after treatment with the combination of IFN-γ and TNF-α ( i ) or co-cultured with OT-I Cells ( j ), either in the presence or absence of GS-4997 ( n = 6 independent samples for control, IFN-γ + TNF-α, and OT-I treatments; n = 3 for presence of GS-4997). Tumor growth curves ( k ) and tumors ( l ) for MC38 control or MDA5 knockout tumors in immunocompetent C57BL/6 mice treated with or without JNK and p38 inhibitors. ( n = 8 tumors/group). Tumor growth curves ( m ) and tumor weight ( n ) for Ctrl, Ctrl-TNFR1 KO - IFNGR1 KO , MDA5 KO and MDA5 KO - TNFR1 KO - IFNGR1 KO MC38 tumors in immunocompetent C57BL/6 mice. ( n = 10 tumors/group). Data are presented as the mean ± SEM in ( b , k , m ), and mean ± SD in ( c , f , g , i , j , n ). Statistics were applied using two-way ANOVA with Tukey’s multiple comparisons test ( f , g , i–n ). Created in BioRender. Zhitong, N. (2026) https://BioRender.com/pvldmia ( a , d ). Source data are provided as a Source Data file.
Article Snippet: CT26 colon adenocarcinoma cells (ATCC, Cat# CRL-2638, RRID: CVCL_7256), B16-F10 melanoma cells (ATCC, Cat# CRL-6475, RRID: CVCL_0159), Hepa1-6 Hepatocellular carcinoma cells (ATCC, Cat# CRL-1830, RRID: CVCL_0327), HCT-15 colorectal cancer cells (ATCC, Cat# CCL-225, RRID: CVCL_0292) and
Techniques: In Vivo, Competitive Binding Assay, Control, Tumor Implantation, Co-culture Assay, Knock-Out, Transformation Assay, Triple Knockout, Analysis, Cell Culture, Co-Culture, FACS